课题基金 / 基金详情

Characterization of Drug Substances in a Dual Indication Vaginal Ring for Prevention of HIV and Pregnancy

Characterization of Drug Substances in a Dual Indication Vaginal Ring for Prevention of HIV and Pregnancy
用于预防艾滋病毒和怀孕的双适应症阴道环中药物成分的表征
批准号：
10697056
负责人：
PETER SILVERA
金额：
$45.51万
依托单位：
ADVANCED BIOSCIENCE LABORATORIES, INC.
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
项目状态：
已结题
起止时间：
2022-09-01 至 2023-08-31
来源：
https://reporter.nih.gov/project-details/10697056
关键词：
AIDS preventionAnimal ModelAreaCharacteristicsCollaborationsContractorContractsDapivirineDosage FormsHIVInvestigator-Initiated ResearchLevonorgestrelMorphologyNational Institute of Allergy and Infectious DiseasePharmaceutical PreparationsPregnancyPreventionResourcesServicesTechnologyVaginal Ringmicrobicideparticlepre-clinicalproduct developmentresearch study

项目摘要

项目成果

PETER SILVERA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of the Comprehensive Resources for Microbicides and Biomedical Prevention contract is to provide the NIAID with a comprehensive suite of preclinical product development services for candidate products that emerge from investigator-initiated research studies or from collaborations with outside companies or organizations. The Contractor shall provide: 1) Preclinical gap-filling services; 2) HIV animal models supporting product development; 3) Bioanalytical support services; 4) Product manufacturing; and 5) Scientific and quality/regulatory support services.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
Expertise in Development of Pediatric Drug Formulations
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services
海外基金